Concepedia

Nienke de Haas

ND

7

Publications

253

Citations

7

H-Index

2016

Active since

Affiliations

Radboud University Nijmegen(Current)

Radboud Institute for Molecular Life Sciences

Radboud University Medical Center

The University of Western Australia

University of Amsterdam

Nienke de Haas is an author at Radboud University Nijmegen specializing in autoimmunity, cellular biochemistry, and proteomics.

ORCID

Top concepts

Publications per year

2016–2021

7

Publications

7

Human CD1c<sup>+</sup> DCs are critical cellular mediators of immune responses induced by immunogenic cell death

Stefania Di Blasio, Inge M. N. Wortel, Diede A.G. van Bladel et al. · OncoImmunology · 2016 · 98 citations · Full text

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

Steve Boudewijns, Martine Bloemendal, Nienke de Haas et al. · Cancer Immunology Immunotherapy · 2020 · 58 citations · Full text

Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients

Glenn F. van Wigcheren, Nienke de Haas, Tom A. Mulder et al. · OncoImmunology · 2021 · 32 citations · Full text

Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients

Florian Wimmers, Nienke de Haas, Anja Scholzen et al. · Scientific Reports · 2017 · 26 citations · Full text

Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity

Stanleyson V. Hato, Carl G. Figdor, Susumu Takahashi et al. · Oncotarget · 2017 · 17 citations · Full text

Rows per page

1–5 of 7